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Highlights 
Phenyl-/aminoalkylsilane-grafted silica gels were used as supports for CaLB. 
Adsorption onto mixed-function-grafted silica supports resulted in active CaLB. 
CaLB adsorption and glutardialdehyde cross-linking resulted in enhanced durability. 
The novel CaLB biocatalysts were used in kinetic resolutions of a secondary alcohol and an amine. 
The novel CaLBs were robust biocatalysts in continuous-flow biotransformations. 
 
Abstract 
Adsorption onto solid supports has proven to be an easy and effective way to improve the 
mechanical and catalytic properties of lipases. Covalent binding of lipases onto the support 
surface enhances the active lifetime of the immobilized biocatalysts. Our study indicates that 
mesoporous silica gels grafted with various functions are ideal supports for both adsorptive 
and covalent binding for lipase B from Candida antarctica (CaLB). Adsorption of CaLB on 
phenyl-functionalized silica gels improved in particular its specific activity, whereas 
adsorption on aminoalkyl-modified silica gels enabling covalent binding with the proper 
reagents resulted in only moderate specific activity. In addition, adsorption on silica gels 
modified by mixtures of phenyl- and aminoalkyl silanes significantly increased the 
productivity of CaLB. Furthermore, CaLB adsorbed onto a phenyl/aminoalkyl-modified 
surface and then treated with glutardialdehyde (GDA) as cross-linking agent provided a 
biocatalyst of enhanced durability. Adsorbed and cross-linked CaLB was resistant to 
detergent washing that would otherwise physically deactivate adsorbed CaLB preparations. 
The catalytic properties of our best immobilized CaLB variants, including temperature-
dependent behavior were compared between 0 and 70 °C with those of two commercial CaLB 
biocatalysts in the continuous-flow kinetic resolutions of racemic 1-phenylethanol rac-1a and 
1-phenylethanamine rac-1b. 
1. Introduction 
Enzyme-catalyzed transformations have gained ever increasing importance in modern 
synthetic processes [1], [2], [3] and [4]. The application of enzymes in their native forms, 
however, suffers several drawbacks. In aqueous solutions, enzymes are relatively unstable, 
and their recovery may be difficult due to their water solubility. Immobilization resulting in a 
reusable and stable heterogeneous phase form of the enzyme greatly extends the scope of their 
application in industrial processes [5]and [6]. Moreover, immobilized enzymes are recyclable, 
easy to store and handle and may show enhanced stability, activity and selectivity compared 
to their native forms [1], [7], [8], [9], [10], [11] and [12]. 
It was found that optimum performance of the immobilized enzymes in a given 
transformation may be attained by applying different enzyme immobilization strategies 
[13] and [14]. Therefore, the nature of the solid support in enzyme immobilization is 
particularly important [6], [11], [15] and [16]. Porous silica gels [15], [17], [18] and [19] and 
particularly mesoporous silica gels (MPSs) [20] and [21] have been shown to be useful 
carriers for enzyme immobilization due to their large surface area, tunable porosity, low 
cytotoxicity, favorable mechanical properties and functionalizable large surface. Modification 
by surface functionalization can widen their applicability as carriers for proteins and enzymes 
[20] and [21]. Cholesterol esterase (CE) combined with five different types of MPSs differing 
in structural properties such as pore diameter, pore volume, and particle morphology 
exhibited various catalytic activities [22]. Grafting the surface of MPSs of large pore size 
(22.5 nm) with various functions (such as decyl) resulted in improved immobilized CE 
biocatalysts with enhanced recyclability and thermal stability [22]. 
MPSs with amino functions on their surfaces enable either adsorptive or covalent 
immobilization. For example, an ordered MPS functionalized by post-synthesis grafting with 
(3-aminopropyl)triethoxysilane (APTEOS) was used for adsorptive immobilization of lipase 
from porcine pancreas (PPL), resulting in a higher hydrolytic activity and better reusability 
than when the enzyme was adsorbed on non-grafted MPS [23]. 
Amino functions on the surface of enzymes treated with suitable cross-linking agents such as 
glutardialdehyde (GDA) in the presence of a precipitant enable supportless immobilization by 
the preparation of cross-linked enzyme aggregates (CLEAs) which are efficient immobilized 
biocatalysts [24] even on an industrial scale [25]. 
In addition to immobilization, reactor technology may offer further means of upgrading of the 
efficacy of biotransformations. In recent years continuous-flow technology has received 
increasing attention and is becoming a promising alternative to batch processes [26] and [27]. 
Most of the continuous-mode biocatalytic syntheses of optically active chiral intermediates on 
a relatively large scale are performed using immobilized lipases in packed-bed reactors [28]. 
Stainless steel continuous-flow packed-bed bioreactors can be effectively used to study the 
effects of temperature, pressure and flow rate on stereoselective biotransformations such as 
lipase-catalyzed kinetic resolutions [29], [30], [31] and [32]. 
Among readily available lipases lipase B from Candida antarctica (CaLB) exhibits many 
attractive characteristics and has thus become one of the most widely used biocatalysts in both 
industrial applications and scientific research [3], [33], [34] and [35]. Recently, it was 
demonstrated that during the continuous-flow kinetic resolution of various amines using 
differently immobilized CaLB biocatalysts the character of the temperature effect in the range 
of 0–70 °C depended significantly both on the substrate and on the mode of immobilization 
[36]. 
Immobilization of CaLB on butyl- [37] or octyl-silica [19] and [38] has indicated the 
usefulness of surface-modified silica as lipase carrier. Surface-modified silica supports, 
especially butyl silica, have proven to be suitable carriers for CaLB-catalyzed reactions in 
ionic liquid/supercritical carbon dioxide biphasic media [39]. A study with a series of grafted 
silica gels indicated phenyl-silica as ideal support for CaLB securing satisfactory selectivity in 
the kinetic resolution of racemic 1-phenylethanol rac-1a, while the octyl-silica-adsorbed 
CaLB had poor activity with good enantiomer selectivity [40]. However, the aminopropyl-
silica adsorption resulted in CaLB biocatalysts of moderate performance [39]. 
Covalent immobilization of CaLB on amino-silica supports indicated that the thermal stability 
of such biocatalysts was better than those prepared by physical adsorption only [41]. CaLB 
adsorbed and cross-linked on a polypropylene carrier maintained its activity when dispersed 
in ionic liquids [42]. 
Coating an MPS with a mixture of the grafting reagents 4-aminophenyltrimethoxysilane and 
phenyltrimethoxysilane at different ratios demonstrated that the density of the amino groups 
present on the silica surface can be successfully controlled while keeping the overall number 
of grafts constant [43]. Thus, a simple method can secure tunable and even dispersion of 
amino functionality on the surface. 
In the present work we set out to compare the usefulness of biocatalysts prepared by simple 
adsorption of CaLB with adsorption combined with cross-linking and covalent binding onto 
surface-functionalized silica supports with dispersed amino functions as novel biocatalysts in 
both in batch and continuous-flow mode. 
2. Materials and methods 
2.1. Materials 
Racemic 1-phenylethanol (rac-1a), racemic 1-phenylethanamine (rac-1b), glutardialdehyde 
(GDA) solution (25%, w/v in H2O), vinyl acetate, sodium chloride, mono- and dibasic sodium 
phosphate, Trizma® base (2-amino-2-hydroxymethyl-1,3-propanediol; Tris base), 
hydrochloric acid and Triton™ X-100 (4-(1,1,3,3-tetramethylbutyl)phenyl-polyethylene 
glycol) were purchased from Sigma–Aldrich. 
Davisil® 150 [35–70 μm] (Dv150), Davisil® 250 [40–63 μm] (Dv250), Daraclar® 915 
(Dc915) and Daraclar® 920 (Dc920) were the products of Grace (Deerfield, USA). Geduran® 
Si 60 [63–200 μm] (Ged60) was purchased from Merck (Darmstadt, Germany). Silica 
supports functionalized with phenyltrimethoxysilane (PTMOS), octyltrimethoxysilane 
(OTMOS), (3-aminopropyl)trimethoxysilane (APTMOS), [3-(2-
aminoethylamino)propyl]trimethoxysilane (AEAPTMOS), [3-(2-
aminoethylamino)propyl]methlydimethoxysilane (AEAP-MDMOS) and with various 
mixtures of such organosilanes were produced by SynBiocat Ltd (Budapest, Hungary). The 
labels for the functionalized silica supports indicate both the nature of the grafted silica gel 
and the grafting reagents. For example, Geduran® Si 60 grafted with OTMOS is labeled as 
Ged60O or Davisil® 250 grafted with a PTMOS:AEAP-MDMOS 1:1 mixture is labeled as 
Dv250PAEAP11. 
Novozym® 435 (CaLB N 435, recombinant lipase B from Candida antarctica expressed in 
Aspergillus niger and adsorbed on acrylic resin) and Novozym® CaLB L recombinant (lipase 
from Candida sp. expressed in Aspergillus niger with a protein content ∼4%, ≥5000 LU/g) 
were obtained from Sigma–Aldrich (Saint Louis, MO, USA). CaLB T2-150 (Candida 
antarctica lipase B covalently attached to dry acrylic beads with a 150–300 μm particle size) 
was the product of ChiralVision BV (Leiden, The Netherlands). 
Solvents (toluene, ethyl acetate, acetone, n-hexane, methyl tert-butyl ether, dichloromethane 
and 2-propanol) from Molar Chemicals (Budapest, Hungary) were dried and/or freshly 
distilled prior to use. 
2.2. Methods 
Thin-layer chromatography was carried out using Kieselgel 60 F254 (Merck) sheets. Spots 
were visualized under UV light (Vilber Lourmat VL-6.LC, 254 nm and 365 nm) or by 
treatment with 5% ethanolic phosphomolybdic acid solution and heating of the dried plates. 
Reactions yielding 2a from 1a were analyzed by gas chromatography (GC) on Agilent 4890 
equipment [FID: 250 °C, injector: 250 °C, carrier gas: H2 (12 psi), split ratio: 1:50] using a 
Hydrodex β-6TBDM column (Machery-Nagel, 25 m × 0.25 mm × 0.25 μm, heptakis-(2,3-di-
O-methyl-6-O-t-butyldimethylsilyl)-β-cyclodextrin); GC data (oven program: 120 °C, 
8 min−1; molar response factor for 2a/1a: 1.23): tr (min): 4.0 [(S)-2a], 4.4 [(R)-2a], 5.8 [(R)-
1a], 6.0 [(S)-1a. Reactions yielding 2b from 1b were analyzed on Agilent 5890 equipment 
[FID: 250 °C, injector: 250 °C, carrier gas: H2 (12 psi), split ratio: 1:50] using a Hydrodex β-
TBDAc column (Machery-Nagel; 25 m × 0.25 mm × 0.25 μm, heptakis-(2,3-di-O-acetyl-6-O-
t-butyl-dimethylsilyl)-β-cyclodextrin); GC data (oven program: 100–180 °C, 8 °C min−1, 
5 min at 180 °C; molar response factor for 2b/1b: 1.17): tr (min): 2.9 [(S)-1b], 3.1 [(R)-1b], 
9.8 [(R)-2b], 10.0 [(S)-2b]. All data in Tables and Figures arose from a precise integration of 
chromatograms in which both enantiomers of the substrates 1a, b and the products 2a, b were 
clearly visible. When peaks for the minor enantiomers were indistinguishable from noise, 
solid curves were replaced by dashed lines in Fig. 4 and Fig. 5. 
Conversion (c), enantiomeric excess (ee) and enantiomeric ratio (E) were determined by GC. 
Enantiomeric ratio (E) was calculated from c and enantiomeric excess of the product (eeP) 
using the equation E = ln[1 − c(1 + eeP)]/ln[1 − c(1 − eeP)] [44]. Due to its sensitivity to 
experimental error E values in the 100–200 range are given as >100, in the range of 200–500 
as >200 and above 500 as ≫200. 
In batch reactions, the specific activity of the biocatalyst (UB) was determined using the 
equation UB = (nrac × c)/(t × mB) [32]. To characterize the productivity of the biocatalysts, the 
specific reaction rates in the batch reactions (rbatch) were calculated using the equation 
rbatch = nP/(t × mB) (where nP [μmol] is the amount of the product, t [min] is the reaction time 
and mB [g] is the mass of the biocatalyst) [44]. Specific reaction rates in continuous-flow 
systems (rflow) were calculated using the equation rflow = [P] × v/mB (where [P] [μmol mL−1] is 
the molar concentration of the product, v [mL min−1] is the flow rate and mB [g] is the mass of 
the biocatalyst) [44]. Because the rate of product formation is not a linear function of c, 
rigorous comparisons by the r values between the productivity of a continuous-flow reaction 
and its batch mode counterpart can only be made at similar degrees of conversions [44]. 
2.3. General procedure for lipase adsorption to silica supports 
CaLB L (1.25 mL, ≥6250 LU/g, ∼5 mg protein) was dissolved in Tris buffer (11.25 mL, 
100 mM, pH = 7.5, ionic strength controlled with NaCl to 175 mM), an then the support 
(250 mg) was added to the solution. The enzyme-support suspension was incubated at 
400 rpm and 4 °C for 18 h. The immobilized CaLB was filtered off on glass filter (G4), 
washed with 2-propanol (2 × 5 mL) and hexane (5 mL), dried for 2 h at room temperature and 
stored at 4 °C. The properties of CaLBs immobilized by adsorption are shown in Table 1 
(Entries 2–16), Table 2 (Entries 2–4) and Table 3 (Entries 1–9). The labels of the CaLB 
biocatalysts immobilized by adsorption indicate the nature of support and the mode of 
immobilization. For example, CaLB adsorbed on Ged60P is labeled as CaLB Ged60P-A or 
CaLB adsorbed on Dv250PAP31 support is labeled as CaLB Dv250PAP31-A. 
2.4. Cross-linked enzyme aggregates (CLEA) from Candida antarctica B lipase 
Cross-linked CaLB aggregates were prepared using the slightly modified method of López-
Serrano et al. [45]. To a mixture of liquid CaLB L (1.0 mL) and phosphate buffer (2 mL, 
0.1 M, pH = 7.5) acetone (6 mL) and GDA solution (160 μL) were added subsequently. The 
mixture was incubated at 400 rpm and 4 °C for 17 h. After addition of more acetone (2 mL), 
the resulting slurry was centrifuged (50 mL PP Corning centrifuge tubes, 3500 rpm, 
∼2000 × g, 7 °C, 20 min, Hermle Z400 K). The supernatant was decanted and the residue was 
washed with acetone (3× 10 mL), centrifuged (3500 rpm, ∼2000 × g, 7 °C, 20 min) and 
decanted. The resulting preparation was dried at room temperature for 0.5 h and stored at 
4 °C. The properties of CaLB CLEA are shown in Table 2 (Entry 1). 
2.5. Cross-linking and covalent binding of CaLB onto silica supports 
Cross-linked CaLB preparations on silica supports were produced using a process similar to 
that described in Section 2.4 with the exception of the addition of adsorbed CaLB 
preparations [Table 2 (Entries 2–4) and Table 3 (Entries 1–9)] instead of CaLB L. Thus, 
acetone (6 mL) and GDA solution (160 μL) were added to the suspension of silica-supported 
CaLB (100 mg) in a phosphate buffer (2 mL, 0.1 M, pH = 7.5) and the mixture was shaken at 
400 rpm and 4 °C for 17 h. After the addition of acetone (2 mL), the suspension was 
centrifuged (50 mL PP Corning centrifuge tubes, 3500 rpm, ∼2000 × g, 7 °C, 20 min, Hermle 
Z400 K). The supernatant was decanted and the residue was washed with acetone (3× 10 mL), 
centrifuged (3500 rpm, ∼2000 × g, 7 °C, 20 min) and decanted. The enzyme preparation was 
dried for 0.5 h at room temperature and stored at 4 °C. The properties of CaLBs immobilized 
by cross-linking and covalent binding to amino-grafted silica supports are shown in Table 2 
(Entries 5–7) and Table 3 (Entries 10–18). The labels of the CaLB biocatalysts immobilized 
by adsorption and cross-linking also indicate the nature of support and the mode of 
immobilization. For example, CaLB adsorbed and cross-linked on Dv250AP support is 
labeled as CaLB Dv250AP-C or CaLB adsorbed and cross-linked on Dv250PAP31 support is 
labeled as CaLB Dv250PAP31-C. 
 
 
2.6. Enzyme desorption tests 
Samples of the CaLB biocatalysts (100 mg each) were treated at room temperature for 1.5 h 
with a phosphate buffer (5 mL; 100 mM; pH = 7.5) or a 2% (v/v) solution of Triton X-100 in 
the same buffer (5 mL) in a shaker at 400 rpm. The samples were then filtered on a glass filter 
(G4) and washed with distilled water (2 × 5 mL; only for the Triton X-100 treated samples), 
2-propanol (2 × 5 mL) and hexane (5 mL). 
2.7. Packed-bed columns filled with immobilized CaLB 
Immobilized CaLBs [CaLB N 435, CaLB T2-150, CaLB Dv250P (Table 1, Entry 15), CaLB 
Dv250PAP13-A (Table 3, Entry 3) and CaLB Dv250PAP13-C (Table 3, Entry 12)] were 
packed into stainless steel CatCart™ columns (70 mm × 4 mm) according to the filling 
procedure of ThalesNano Inc. Before packing, the columns were washed with distilled water, 
ethanol, n-hexane and acetone in ultrasonic cleaner. The columns were capped with silver 
metal filter membranes [Sterlitech Silver Membrane Filter from Sigma–Aldrich, Z623237, 
pore size 0.45 μm; pure metallic silver, 99.97% purity with no extractable or detectable 
contaminants]. The known benefit of Ag is its bacteriostatic activity. Sealings were made by 
PTFE. Three CatCart™ columns per enzyme (separate columns for each substrate, rac-1a and 
rac-1b) were packed (filling weights: CaLB N 435, 282 ± 14 mg; CaLB T2-150, 262 ± 3 mg; 
CaLB Dv250P, 247 ± 6 mg; CaLB Dv250PAP13-A, 260 ± 25 mg and CaLB Dv250PAP13-C, 
288 ± 5 mg). 
2.8. Kinetic resolution of racemic 1-phenylethanol rac-1a in batch mode 
Immobilized CaLB (50 mg) was added to a solution of the racemic 1-phenylethanol rac-1a 
(50 μl; 50.6 mg; 0.41 mmol) in hexane/methyl t-butyl ether/vinyl acetate 6/3/1 (v/v) mixture 
(1 mL) in a screw-capped amber glass vial and the resulting mixture was shaken (1000 rpm) 
at 30 °C for 4 h. Samples (10 μL) from each reactions were taken at 4 h for silica support 
screening (Table 1) and at 1, 2 and 4 h for further tests. After dilution with dichloromethane 
(250 μL), the samples were analyzed by GC as described in Section 2.2. 
2.9. Kinetic resolution of racemic 1-phenylethanol rac-1a and racemic 1-
phenylethanamine rac-1b in continuous-flow bioreactor 
Continuous-flow kinetic resolutions were performed in a laboratory flow reactor built from a 
Knauer K-120 isocratic HPLC pump attached to CatCart™ columns filled with the 
immobilized CaLB biocatalysts in an in-house made aluminum metal block column holder 
with precise temperature control. The CaLB-filled columns were washed with a dry 
hexane/methyl t-butyl ether 2/1 mixture (0.5 mL min−1, 20 min) before reactions with rac-1a 
or a dry toluene/ethyl acetate 9/1 mixture (0.5 mL min−1, 20 min) before reactions with rac-
1b. 
The solution of racemic 1-phenylethanol rac-1a (10 mg mL−1; 0.082 M) in dry hexane/methyl 
t-butyl ether/vinyl acetate 6/3/1 or racemic 1-phenylethanamine rac-1b (10 mg mL−1; 
0.083 M) in dry toluene/ethyl acetate 9/1 were pumped through the enzyme-filled column set 
to various temperatures (0–70 °C) at a flow rate of 0.4 mL min−1 for rac-1a or 0.2 mL min−1 
for rac-1b. Samples were analyzed by GC every 10 min up to 40 min to allow the 
establishment of a stationary state. Samples were collected during stationary operation 
(30 min after changing the parameters) and analyzed as described in Section 2.2. 
After completing experiments at a series of temperatures (0–70 °C in 10 °C steps), the 
columns were routinely washed with hexane (0.5 mL min−1, 20 min, for reactions with rac-
1a) or toluene (0.5 mL min−1, 20 min, for reactions with rac-1b) and then stored at 4 °C. 
3. Results and discussion 
In this study our aim was to evaluate various immobilization methods of lipase B from 
Candida antarctica using adsorption and adsorption combined with cross-linking and 
covalent binding onto surface functionalized silica supports with dispersed amino functions 
and to compare our best performing novel biocatalysts with those prepared by other 
immobilization procedures in both batch and continuous-flow modes. 
3.1. Selection of silica gel supports 
First, the performance of five silica gels with different particle sizes and pore diameters 
[Davisil® 150: 35–70 μm, 150 Å (Dv150); Davisil® 250: 40–63 μm, 250 Å (Dv250); 
Daraclar® 915 (Dc915); Daraclar® 920 (Dc920); and Geduran® Si 60: 63–200 μm, 60 Å 
(Ged60)] and their octyl- and phenyl-grafted variants were tested as inorganic support for 
adsorption of CaLB from a buffer (100 mM Tris, pH = 7.5) solution. The catalytic 
performance of the resulting biocatalysts was characterized by the kinetic resolution of 
racemic-1-phenylethanol rac-1a (Table 1). 
Specific activity values of our biocatalysts (UB, at 4 h) compared with that of an efficient 
commercial version of immobilized CaLB (N 435: UB = 17.7 U g−1) indicated that some of 
our silica gel-based CaLB preparations already performed similarly (e.g., Dv250P: 
UB = 16.6 U g−1 or Dc915P: UB = 16.4 U g−1). In accordance with our recent result on the 
adsorptive immobilization of CaLB onto various hydrophobic silica gels [36] in the kinetic 
resolution of rac-1a, CaLB on phenyl-grafted silica supports was always more active than that 
adsorbed on octyl-grafted silica. Surprisingly, with the exception of DV150, CaLB on 
untreated silica supports resulted in more active biocatalysts than those on octyl-grafted silica. 
Although CaLB adsorption on the phenyl-grafted versions of silica materials designed for 
protein removal in breweries (Dc915 and Dc920) gave quite active and selective biocatalysts, 
their usefulness in synthetic biotransformations is limited due to their rather small particle 
size. Because the best overall performance was achieved by CaLB adsorbed on phenyl-grafted 
mesoporous silica gel (Dv250P: pore diameter 250 Å), Dv250 was chosen as the support for 
further investigations. 
3.2. CaLB immobilization by adsorption and adsorption combined with cross-linking on 
amino-functionalized silica gels 
Our further goal was to combine the benefits of adsorption and covalent binding onto amino-
silica and to prepare cross-linked enzyme aggregates and in this way to further improve the 
stability of immobilized CaLB. It was shown that covalent immobilization of CaLB on 
amino-silica resulted in better thermal stability of the enzyme than simple physical adsorption 
[41]. In addition, CaLB adsorbed and cross-linked on a polypropylene carrier also exhibited 
advantageous properties [42]. It was therefore assumed that adsorption on a proper support 
carrying amino functions followed by GDA cross-linking may provide a more stable cross-
linked CaLB that is also attached at the same time to the support by covalent bonds. As a first 
approach, a Dv250 support was grafted with (3-aminopropyl)trimethoxysilane (APTMOS), 
[3-(2-aminoethylamino)propyl]trimethoxysilane (AEAPTMOS) and [3-(2-
aminoethylamino)propyl]methlydimethoxysilane (AEAP-MDMOS) and the amino-silica 
supports thus obtained were tested with CaLB for adsorption (A) and adsorption followed by 
GDA cross-linking (C) (Table 2). The resulting CaLB preparations were also compared with 
non-supported CLEA of CaLB (Table 2). Adsorption of CaLB on amine-functionalized silica 
gels (method A in Table 2) gave less useful biocatalysts than adsorption on phenyl silica (e.g., 
E ≫ 200 of Dv250P-A vs. E > 200 with Dv250AP-A). A further significant drop of specific 
activity was found when adsorption was combined with GDA cross-linking on amine-
functionalized silica gels (method C in Table 2). 
3.3. Adsorption and adsorption combined with cross-linking and covalent binding of 
CaLB onto mixed-function-grafted silica gels containing dispersed amino moieties 
A simple one-pot process of grafting mesoporous silica gel with a mixture of amino-
functionalized and amine-free silanes at different ratios indicated that it is possible to control 
the dispersion of functionality present on the silica surface [43]. This finding combined with 
the promising adsorption results of hydrophobic grafting of silica gel (Table 1) led to the 
conclusion that the moderate performance involving adsorption (A) and adsorption combined 
with GDA cross-linking (C) onto aminoalkyl-grafted silica supports (Table 2) can be 
improved by dispersing the aminoalkyl functions with the best performing phenyl-grafting. 
Accordingly, three mixed-grafting series were prepared using mixtures of PTMOS:APTMOS, 
PTMOS:AEAPTMOS and PTMOS:AEAP-MDMOS (at ratios of 3:1, 1:1 and 1:3 in each 
series) for surface modification, and the resulting phenyl-dispersed amino-silica supports were 
tested for adsorption (A) and for adsorption and GDA cross-linking/covalent binding (C) with 
CaLB (Table 3). 
Compared to the solely aminoalkyl-grafted variants, adsorption of CaLB on the dispersed-
amino-silica supports (method A in Table 3) resulted in higher productivity (e.g., 
UB = 17.1 U g−1 of Dv250AP-A raised to UB = 57.0, 59.9 and 60.5 U g−1 with Dv250PAP13-
A, Dv250PAP11-A and Dv250PAP31-A, respectively) and higher selectivity (e.g., E > 200 of 
Dv250AP-A raised to E ≫ 200 for all three Dv250PAP-A biocatalysts). Adsorption of CaLB 
onto supports with a grafting mixture with higher phenyl content gave more productive 
biocatalysts within all three series (method A in Table 3). 
The positive effect of dispersing the amino functions with the aid of phenyl moieties on the 
productivity of the biocatalysts was even more pronounced when adsorption of CaLB onto the 
supports was combined with GDA cross-linking (method C in Table 3: e.g., UB = 4.2 U g−1 of 
Dv250AP-C raised to UB = 16.4, 29.9 and 44.0 U g−1 with Dv250PAP13-C, Dv250PAP11-C 
and Dv250PAP31-C, respectively), and selectivity was maintained at a satisfactory level 
(E > 100). Within all three aminoalkyl–phenyl series (aminoalkyl–phenyl ratios of 3:1, 1:1 
and 1:3) a higher phenyl content proved to be the best (e.g., UB = 16.4 U g−1 of Dv250PAP13-
C increased to UB = 44.0 U g−1 with Dv250PAP31-C and E > 100 with Dv250PAP13-C 
increased to E > 200 with Dv250PAP31-C). 
However, adsorption combined with GDA cross-linking and covalent binding (C) compared 
with adsorption (A) onto mixed-function-grafted silica gel supports resulted in a slight 
reduction of productivity (e.g., UB = 60.5 U g−1 of Dv250PAP31-A vs. UB = 44.0 U g−1 with 
Dv250PAP31-C) and selectivity (E ≫ 200 with Dv250PAP31-A vs. E > 200 with 
Dv250PAP31-C). 
 
3.4. Morphology of the variously immobilized CaLB biocatalysts 
To gain further insight into the behavior of the novel biocatalysts, the best performing silica-
based CaLB biocatalysts from the present study, i.e. Dv250P-A, Dv250PAP31-A and 
Dv250PAP31-C were compared with the commercial forms of CaLB namely N 435 
(adsorption on acrylic beads) and T2-150 (covalent binding onto acrylic beads) by scanning 
electron microscopy (SEM) (Fig. 1). Analysis at 150× magnification revealed the expected 
particle sizes of the various CaLB preparations (∼500 μm for N 435, 150–300 μm for T2-150, 
and 35–90 μm for Dv250P-A, DV250PAP31-A and DV250PAP31-C) and no particle 
aggregations in all cases. Notably it was the pore structure and the available surface area and 
not the particle size that most influenced the activity of immobilized enzymes. Larger 
magnifications (1000–3000×) indicated uniform surface coverage of the two commercial 
CaLB preparations (N 435 and T2-150) and also of the two silica-based CaLBs immobilized 
by adsorption (Dv250P-A and Dv250PAP31-A). In contrast, adsorption combined with cross-
linking (Dv250PAP31-C) resulted in the formation of a non-homogeneous surface with 
attached aggregated protein particles. Increased limitation of diffusion within these aggregates 
of 0.5–2 μm size may explain the diminished specific activity of Dv250PAP31-C CaLB 
compared with Dv250PAP31-A CaLB. 
 
3.5. Desorption behavior of the various immobilized CaLB biocatalysts 
In addition to SEM studies, the CaLB preparations N 435, T2-150, Dv250P-A, Dv250PAP31-
A and Dv250PAP31-C were investigated in enzyme desorption tests. The biocatalysts were 
treated for 1.5 h at room temperature with phosphate buffer (100 mM; pH = 7.5) and 
separately with a 2% (v/v) solution of Triton X-100 in the same buffer (Fig. 2). Although 
three of the five CaLB biocatalysts tested (N 435, Dv250P-A and Dv250PAP31-A) were 
immobilized only by physical adsorption, all of them retained at least 66% of their initial 
specific activity (UB0) after treatment with phosphate buffer. Interestingly, treatment with 
phosphate buffer only even led to enhanced specific activity (UB/UB0 = 143% and 105% for 
T2-150 and Dv250P-A CaLB, respectively). However, all of the CaLB biocatalysts 
immobilized by physical adsorption only (N 435, Dv250P-A and Dv250PAP31-A) lost at 
least 50% of their initial specific activity (UB0) upon treatment with 2% Triton X-100. The 
most durable CaLB biocatalyst against Triton X-100 desorption was Dv250PAP31-C, an 
adsorbed and GA cross-linked CaLB bound to aminopropyl-phenyl-grafted silica, which 
retained 83% of its initial activity. This high degree of stability of Dv250PAP31-C CaLB may 
compensate for its lower degree of activity compared with that of the most active 
Dv250PAP31-A CaLB (Dv250PAP31-C: UB = 44.0 U g−1, Dv250PAP31-A: 
UB = 60.5 U g−1). 
 
3.6. Performance of the variously immobilized CaLB biocatalysts in the kinetic 
resolution of the alcohol rac-1a and the amine rac-1b 
A recent study demonstrated that the various modes of immobilization of CaLB significantly 
influenced the character of the temperature effect on the catalytic properties of the enzyme in 
continuous-flow kinetic resolution of racemic amines [36]. Our further aim was now to extend 
our investigations on the temperature dependence of O-acylation with various forms of CaLB 
as well (Fig. 3). Therefore the temperature effect (in the range of 0–70 °C) was studied with 
our best-performing novel mixed-function-grafted silica gel-based CaLBs on the continuous-
flow kinetic resolution of a typical alcohol such as racemic 1-phenylethanol rac-1a (Fig. 4) 
and a typical amine such as 1-phenylethanamine rac-1b (Fig. 5). 
Five differently immobilized forms of CaLB were selected for the continuous-flow studies. 
The silica gel-based Dv250P-A (adsorption onto phenyl silica), Dv250PAP31-A (adsorption 
onto silica grafted with a PTMOS–APTMOS 3:1 mixture) and Dv250PAP31-C (adsorption 
and glutardialdehyde cross-linking onto silica grafted with a PTMOS–APTMOS 3:1 mixture) 
forms of CaLB were compared with Novozym® 435 (CaLB N 435, adsorption onto acrylic 
resin) and CaLB T2-150 (covalently attached to acrylic beads). In this way, a diverse 
selection of various immobilization methods (adsorption on inorganic and organic supports, 
covalent attachment on polymeric support and mixed-mode adsorption and GA cross-linking) 
of CaLB was covered. 
In the continuous-flow kinetic resolutions of 1-phenylethanol rac-1a between 0 and 70 °C, 
significant alterations in the biocatalytic properties of the variously immobilized CaLBs were 
observed (Fig. 4). Productivity (specific reaction rate, rflow) change in the acylation of rac-1a 
followed a sigmoid (Dv250P-A) or a hyperbolically ascending curve (Dv250PAP31-A and N 
435) for the physically adsorbed CaLBs, whereas a hyperbolically ascending increase in rflow 
was found for the covalently bound and for the adsorbed and covalently cross-linked CaLBs 
(T2-150 and Dv250PAP31-C) representing conformationally more-restricted forms of the 
enzyme. 
The effect of enzyme flexibility was even more significant on the selectivity of the kinetic 
resolutions of rac-1a. The physically adsorbed, conformationally more flexible CaLBs 
(Dv250P-A, Dv250PAP31-A and N 435) behaved similarly and showed selectivity maxima at 
approximately 20 °C (curves for ee(R)-2c and E in Fig. 4). Conformational restrictions of the 
enzyme in the covalently bound CaLBs (Dv250PAP31-C and T2-150) resulted in a significant 
loss of selectivity. Thus, e.g. ee = 99.65% and E ∼ 700 at 20 °C was found for Dv250PAP31-
C compared with the only adsorbed and therefore less-restricted CaLBs, e.g., Dv250PAP31-
A, with ee = 99.87% and E ∼ 2000 at 20 °C. Although the nature of the selectivity change as 
a function of temperature with covalently bound CaLBs (Dv250PAP31-A and T2-150) 
remained similar with a maximum, these maxima shifted toward higher temperatures (at 
approximately 30–40 °C). The beneficial stabilization effect of cross-linking became obvious 
at 70 °C where the Dv250PAP31-C form of CaLB retained the highest enantiomer selectivity 
(ee = 99.5% and E ∼ 750) among all of the five CaLB forms. 
For the continuous-flow kinetic resolutions of 1-phenylethanol rac-1a, the catalytic activity of 
the CaLB N435 chosen as a standard was higher (rflow = 37.2 μmol min−1 g−1 at 20 °C in a 
hexane/methyl t-butyl ether/vinyl acetate 6/3/1 mixture with rac-1a) than that found earlier 
(rflow = 10.2 μmol min−1 g−1 at 25 °C in a hexane–THF–vinyl acetate 2:1:1 mixture with rac-
1a[29]. The reusability of the supported biocatalysts investigated in this work was similar as 
found earlier [29], [30], [31] and [32]. For example, no significant drop of activity was 
observed with the CaLB N435 packed in CatCart column after a series of 12 reactions 
performed in continuous-flow biotransformations at various temperatures and pressures 
between 0–60 °C and 1–120 bar (60 min, each; followed by a 30 min long washing) [29]. It 
should be noted here that such precise recovery of activity with ∼0.4 g enzyme is hardly 
possible with batch mode reactions due to the mechanical damage of the biocatalyst even on 
shaking and due to the loss of biocatalyst during filtrations. 
Although the particle size of the silica gel-based CaLB preparations (35–90 μm for Dv250P-
A, DV250PAP31-A and DV250PAP31-C) was much smaller than that for CaLBs based on a 
polymeric support (∼500 μm for N 435, 150–300 μm for T2-150), the pressure drop observed 
on a 70 mm long CatCart™ column was negligible (<2 bar). 
In the continuous-flow kinetic resolutions of 1-phenylethanamine rac-1b at 0–70 °C, 
productivity (specific reaction rate, rflow) changes of the variously immobilized CaLBs were 
different as well (Fig. 5). The rflow in N-acylation of rac-1b followed sigmoid (T2-150 and 
Dv250P-A) or hyperbolically ascending curves (Dv250PAP31-A, Dv250PAP31-C and N 
435). In general, rflow for the N-acylation of rac-1b with ethyl acetate (Fig. 5) was lower than 
in the corresponding O-acylation of rac-1a with vinyl acetate (Fig. 4) for all forms of CaLB. 
However, enantiomer selectivity at temperatures up to 50 °C for the N-acylation of rac-1b 
with ethyl acetate (Fig. 5) was higher than that of the corresponding O-acylation of rac-1a 
with vinyl acetate (Fig. 4) for all forms of CaLB. In accordance with the results of the O-
acylation of rac-1a (Fig. 4), conformational restrictions of the enzyme in the covalently bound 
CaLBs (Dv250PAP31-C and T2-150) resulted in lower enantiomer selectivity in the kinetic 
resolutions of rac-1b compared with the physically adsorbed forms (Dv250PAP31-A, 
Dv250PAP31-C and N 435). Interestingly, in all instances, the drop of the enantiomer 
selectivity during N-acylation of rac-1b above 50 °C was more pronounced than in the kinetic 
resolutions of rac-1b with the same form of CaLB. 
4. Conclusions 
Our study indicates that adsorption and adsorption combined with cross-linking onto 
mesoporous silica gels grafted with various functions were advantageous immobilization 
methods for Candida antarctica lipase B (CaLB). Silica gels modified with mixtures of 
phenyl- and aminoalkyl silanes were better supports for CaLB than those grafted by only one 
of the components. Particularly, the productivity (UB, in batch mode or rflow, in continuous-
flow mode) of the CaLB biocatalyst was enhanced by adsorption onto phenyl/aminoalkyl-
modified silica supports. Compared with the adsorbed CaLBs, the biocatalysts showed 
enhanced durability and a higher degree of enantiomer selectivity at elevated temperatures 
(above 60 °C) with acceptable productivity when CaLB was adsorbed and cross-linked on 
silica gels modified with mixtures of phenyl- and aminoalkyl silanes. 
The study of the temperature-dependent behavior of the variously immobilized forms of 
CaLB between 0 and 70 °C during continuous-flow kinetic resolutions of racemic 1-
phenylethanol 1a and racemic 1-phenylethanamine 1b indicated that the optimal method of 
immobilization depended on both the nature of the substrate and the reaction conditions. If 
higher productivity and selectivity at lower temperatures is important, then immobilization by 
adsorption onto mixed-function-grafted silica gel supports is preferred. If, however, enhanced 
stability and preserved selectivity at elevated temperatures are more important, adsorption 
combined with glutardialdehyde cross-linking on the same support should be used. 
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Table 1.  
Kinetic resolution of rac-1a with CaLB adsorbed on various surface-functionalized 
silica supports (reaction time: 4 h). 
Entry CaLB on Silane for grafting c (%) ee(R)-2a (%) Ea UB (U g−1) 
1 N 435b –b 51.4 98.6 ≫200 17.7 
2 Ged60 –c 29.4 99.6 ≫200 10.1 
3 Ged60P PTMOS 2.8 98.2 >100 1.0 
4 Ged60O OTMOS 3.5 99.1 >200 1.2 
5 Dc915 –c 20.3 99.7 ≫200 7.0 
6 Dc915P PTMOS 47.6 99.6 ≫200 16.4 
7 Dc915O OTMOS 5.6 99.1 >200 1.9 
8 Dc920 –c 20.1 99.5 ≫200 6.9 
9 Dc920P PTMOS 36.5 99.7 ≫200 12.6 
10 Dc920O OTMOS 14.8 99.6 ≫200 5.1 
11 Dv150 –c 7.8 99.2 >200 2.7 
12 Dv150P PTMOS 35.5 99.7 ≫200 12.3 
13 Dv150O OTMOS 16.1 99.5 ≫200 5.6 
14 Dv250 –c 24.3 99.6 ≫200 8.4 
15 Dv250P PTMOS 48.0 99.6 ≫200 16.6 
16 Dv250O OTMOS 14.5 99.6 ≫200 5.0 
aEnantiomeric ratio (E) was calculated from conversion (c) and enantiomeric excess 
(ee(R)-2a) of the product [44]. 
bNovozym® 435, enzyme loading was estimated as described earlier [31]. 
cCaLB adsorbed on non-modified silica supports. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.  
Kinetic resolution of rac-1a with CaLB immobilized by adsorption (A) or by 
adsorption and GDA binding/cross-linking (C) onto various aminoalkyl-grafted silica 
supports (reaction time: 1 h). 
Entry Silane for Dv250 grafting A/C
a CaLB biocatalyst 
on Dv250 
c 
(%)
ee(R)-2a 
(%) E
b UB (U g−1)
1 – c CLEA c 29.5 99.9 ≫200 40.7 
2 APTMOS A AP-A 12.5 99.4 >200 17.1 
3 AEAPTMOS A AEAP-A 6.6 99.4 >200 9.0 
4 AEAP-MDMOS A AEAP-M-A 6.3 99.4 >200 8.6 
5 APTMOS C AP-C 3.1 99.3 >200 4.2 
6 AEAPTMOS C AEAP-C 1.7 99.0 >100 2.3 
7 AEAP-MDMOS C AEAP-M-C 0.8 98.0 >100 1.1 
aImmobilization method: adsorption (A), adsorption and GDA cross-linking (C). 
bEnantiomeric ratio (E) was calculated from conversion (c) and enantiomeric excess 
(ee(R)-2a) of the product [44]. 
cCross-linked CaLB (CaLB CLEA), prepared as described in Section 2.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.  
Kinetic resolution of rac-1a with CaLB immobilized by adsorption (A) or by 
adsorption and GDA binding/cross-linking (C) onto various silica supports grafted 
with mixtures of aminoalkyl- and phenyl-silanes (reaction time: 1 h). 
Entry 
CaLB 
biocatalyst on 
Dv250 
Silanes for Dv250 
grafting Ratio A/C
a c 
(%)
ee(R)-
2a 
(%) 
Eb UB (U g−1)
1 PAP13-A PTMOS:APTMOS 1:3 A 41.4 99.7 ≫200 57.0 
2 PAP11-A PTMOS:APTMOS 1:1 A 43.5 99.8 ≫200 59.9 
3 PAP31-A PTMOS:APTMOS 3:1 A 43.9 99.7 ≫200 60.5 
4 PAEAP13-A PTMOS:AEAPTMOS 1:3 A 37.5 99.8 ≫200 51.7 
5 PAEAP11-A PTMOS:AEAPTMOS 1:1 A 46.8 99.7 ≫200 64.5 
6 PAEAP31-A PTMOS:AEAPTMOS 3:1 A 43.1 99.7 ≫200 59.4 
7 PAEAPM13-A PTMOS:AEAP-MDMOS 1:3 A 44.9 99.8 ≫200 61.9 
8 PAEAPM11-A PTMOS:AEAP-MDMOS 1:1 A 45.2 99.8 ≫200 62.3 
9 PAEAPM31-A PTMOS:AEAP-MDMOS 3:1 A 45.8 99.7 ≫200 63.1 
10 PAP13-C PTMOS:APTMOS 1:3 C 11.9 98.8 >100 16.4 
11 PAP11-C PTMOS:APTMOS 1:1 C 21.7 98.8 >200 29.9 
12 PAP31-C PTMOS:APTMOS 3:1 C 32.0 99.0 >200 44.0 
13 PAEAP13-C PTMOS:AEAPTMOS 1:3 C 10.3 99.1 >200 14.2 
14 PAEAP11-C PTMOS:AEAPTMOS 1:1 C 24.9 99.0 >200 34.4 
15 PAEAP31-C PTMOS:AEAPTMOS 3:1 C 23.7 99.2 >200 32.6 
16 PAEAPM13-C PTMOS:AEAP-MDMOS 1:3 C 18.6 99.5 >200 25.6 
17 PAEAPM11-C PTMOS:AEAP-MDMOS 1:1 C 26.5 99.2 >200 36.6 
18 PAEAPM31-C PTMOS:AEAP-MDMOS 3:1 C 26.1 99.2 >200 36.0 
aImmobilization method: adsorption (A), adsorption and GDA cross-linking (C). 
bEnantiomeric ratio (E) was calculated from conversion (c) and enantiomeric excess 
(ee(R)-2a) of the product [44]. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.  
Scanning electron microscopy (SEM) analysis of immobilized CaLB biocatalysts at 
low (150×) and medium (1000–3000×) magnification. 
 
Fig. 2.  
Enzyme desorption tests of immobilized CaLB biocatalysts with phosphate buffer 
(10 mM, pH 7.5) and Triton X-100 solution (2%, v/v). 
 
Fig. 3.  
Continuous-flow kinetic resolution of racemic 1-phenylethanol rac-1a and racemic 1-
phenylethanamine rac-1b catalyzed by variously immobilized forms of lipase B from 
Candida antarctica. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.  
Temperature-dependent biocatalytic properties (rflow, E and ee(R)-2a) of variously 
immobilized CaLB biocatalysts during the kinetic resolution of racemic 1-
phenylethanol (rac-1a) by acylation with vinyl acetate in continuous-flow reactors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.  
Temperature-dependent biocatalytic properties (rflow, E and ee(R)-2b) of variously 
immobilized CaLB biocatalysts during the kinetic resolution of racemic 1-
phenylethanamine (rac-1b) by acylation with ethyl acetate in continuous-flow 
reactors. 
 
 
 
 
 
 
 
 
 
